Serina Therapeutics (SER) Receivables - Net (2017 - 2024)
Serina Therapeutics (SER) has disclosed Receivables - Net for 8 consecutive years, with $65000.0 as the latest value for Q1 2024.
- Quarterly Receivables - Net rose 983.33% to $65000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Mar 2024, up 983.33% year-over-year, with the annual reading at $57000.0 for FY2023, 1325.0% up from the prior year.
- Receivables - Net hit $65000.0 in Q1 2024 for Serina Therapeutics, up from $57000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $366000.0 in Q1 2020 to a low of $1000.0 in Q3 2022.
- Historically, Receivables - Net has averaged $93375.0 across 5 years, with a median of $36500.0 in 2021.
- Biggest five-year swings in Receivables - Net: plummeted 95.83% in 2022 and later soared 6600.0% in 2023.
- Year by year, Receivables - Net stood at $326000.0 in 2020, then plummeted by 92.33% to $25000.0 in 2021, then crashed by 84.0% to $4000.0 in 2022, then soared by 1325.0% to $57000.0 in 2023, then increased by 14.04% to $65000.0 in 2024.
- Business Quant data shows Receivables - Net for SER at $65000.0 in Q1 2024, $57000.0 in Q4 2023, and $67000.0 in Q3 2023.